($VTVT) vTv therapeutics: developing a drug for Psoriasis. Phase-1 clinical trial result is promising.
# $VTVT

**vTv therapeutics developed HPP737, which is a novel, potent therapeutic use to treat Psoriasis disease ( a chronic inflammatory disease). Their Phase-1 clinical trial has done successfully and found the drug is very well tolerated without any adverse symptoms. Approximately 7.55M US adults have psoriasis.**

[https://ir.vtvtherapeutics.com/news-releases/news-release-details/vtv-therapeutics-announces-results-multiple-ascending-dose-study](https://ir.vtvtherapeutics.com/news-releases/news-release-details/vtv-therapeutics-announces-results-multiple-ascending-dose-study)

Premarket: UP \~20%

​

[https://www.benzinga.com/general/biotech/21/09/23080897/update-vtv-therapeutics-says-hpp737-exhibited-favorable-safety-and-tolerability-profile-with-no-d](https://www.benzinga.com/general/biotech/21/09/23080897/update-vtv-therapeutics-says-hpp737-exhibited-favorable-safety-and-tolerability-profile-with-no-d)
https://www.reddit.com/r/StockMarket/comments/pu6qtm/vtvt_vtv_therapeutics_developing_a_drug_for/